ACMT Position Statement: Guidance for the Use of Intravenous Lipid Emulsion.
D061605:Administration, Intravenous; D000066491:Clinical Decision-Making; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D018579:Patient Selection; D011041:Poisoning / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012307:Risk Factors; D014116:Toxicology / Q000592:standards*; D016896:Treatment Outcome
D005217:Fat Emulsions, Intravenous
Intralipid; Lipid emulsion; Lipid resuscitation; Toxicology